This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Medimmune Limited, Johns Hopkins University. Active years: 2015-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 549 
3 out of 3,806 
Years Active: 2015-2019
Title: **Innovator Sheng Yao: A Pioneer in Antibody Research**
Introduction
Sheng Yao, a distinguished inventor based in Columbia, MD, has made significant contributions to the field of biomedical research through his innovations in antibody development. With a total of four patents to his name, his work focuses on advancing therapies for autoimmune diseases, transplant rejection, and cancer.
Latest Patents
One of Sheng Yao's notable patents is for Anti-B7-H5 antibodies and their uses. This invention involves antibodies and their antigen-binding fragments designed to specifically bind to the B7-H5 ligand within the B7-H5:CD28H pathway. These molecules hold promise for diagnosing and treating autoimmune diseases, transplant rejection, and various inflammatory conditions. Another significant patent under his name is for Anti-H7CR antibodies, which encompasses antibodies, including humanized variants, capable of targeting the B7-H7 counter-receptor, H7CR. This innovation has potential applications in enhancing immune responses and providing therapeutic benefits for cancer and other diseases.
Career Highlights
Sheng Yao has been associated with prominent organizations such as MedImmune Limited and The Johns Hopkins University, where he has collaborated with leading experts in the field. His experience in these esteemed institutions has provided him with a robust platform for conducting advanced research and developing groundbreaking inventions.
Collaborations
Throughout his career, Sheng has worked alongside respected colleagues, including Solomon Langermann and Linda Liu. Together, they have pushed the boundaries of immunology, leading to significant advancements that benefit both scientific understanding and clinical applications.
Conclusion
Sheng Yao stands out as an influential inventor in the realm of antibody research. His innovative patents and collaborative efforts reflect his commitment to addressing critical health challenges through scientific discovery. With a focus on autoimmune diseases and cancer treatment, Yao's contributions are shaping the future of medical therapies and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile